ArticleBone marrow transplantation2022

Venetoclax and azacitidine followed by allogeneic transplant results in excellent outcomes and may improve outcomes versus maintenance therapy among newly diagnosed AML patients older than 60.

Daniel A Pollyea et al.PubMed ↗Publisher ↗

No numbers read from the abstract.